Data / Drug companies / Alaina Healthcare Private Limited
Alaina Healthcare Private Limited: 16 products in the FDA NDC directory, labeler code 73492
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Alaina Healthcare Private Limited (labeler code 73492) lists 16 products in the FDA National Drug Code Directory, covering 16 finished drugs by generic name. By type: 16 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 30, 2026.
The request: Watch Alaina Healthcare Private Limited (FDA labeler code 73492): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 73492
- Products in commercial distribution
- 16
- Packages
- 18
- Finished drugs by generic name
- 16
- Prescription products
- 0
- Over the counter products
- 16
- Flagged as original packager
- 14 of 14 products that carry the flag
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- January 27, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 16 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 16 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Methyl salicylate | 1 | 24 |
| Benzocaine | 1 | 110 |
| Oxymetazoline hydrochloride 0.05% | 1 | 2 |
| Mineral sunscreen | 1 | 8 |
| Capsaicin 0.025% | 1 | 4 |
| Capsaicin | 1 | 66 |
| Sodium chloride | 1 | 71 |
| Camphor, menthol | 1 | 35 |
| Lidocaine hcl | 1 | 48 |
| Camphor, eucalyptus oil and menthol | 1 | 1 |
| 1% hydrocortisone anti-itch | 1 | 1 |
| Menthol and camphor | 1 | 7 |
| Lidocaine 5% anorectal | 1 | 1 |
| Zinc oxide spf 50 | 1 | 1 |
| Saline | 1 | 3 |
| Itch and pain relief | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 7 | 43.8% |
| Spray | 3 | 18.8% |
| Ointment | 3 | 18.8% |
| Lotion | 2 | 12.5% |
| Gel | 1 | 6.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 2 |
| Antiarrhythmic | 2 |
| Copper Absorption Inhibitor | 2 |
| Standardized Chemical Allergen | 1 |
| Vasoconstrictor | 1 |
| Corticosteroid | 1 |
| Histamine-1 Receptor Antagonist | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Itch and pain relief | 73492-802 | Cream | Over the counter monograph drugs | September 30, 2026 |
| Capsaicin 0.025% | 73492-801 | Cream | Over the counter monograph drugs | September 30, 2026 |
| 1% Hydrocortisone Anti-itch | 73492-291 | Cream | Over the counter monograph drugs | July 20, 2026 |
| Saline nasal | 73492-281 | Spray | Over the counter monograph drugs | June 19, 2026 |
| Mineral Sunscreen SPF 50 | 73492-720 | Lotion | Over the counter monograph drugs | June 12, 2026 |
| Pain Relief Balm | 73492-718 | Ointment | Over the counter monograph drugs | October 7, 2025 |
| Methyl Salicylate | 73492-273 | Cream | Over the counter monograph drugs | May 13, 2025 |
| Saline 1.5 FL OZ | 73492-251 | Spray | Over the counter monograph drugs | May 13, 2025 |
| LidoGuard | 73492-272 | Cream | Over the counter monograph drugs | May 12, 2025 |
| Capsaicin Cream 0.075% | 73492-271 | Cream | Over the counter monograph drugs | May 12, 2025 |
| Mineral Sunscreen | 73492-152 | Lotion | Over the counter monograph drugs | March 4, 2025 |
| Oral pain relief | 73492-717 | Gel | Over the counter monograph drugs | December 8, 2023 |
| Severe Nasal | 73492-715 | Spray | Over the counter monograph drugs | September 15, 2023 |
| Vaporizing Rub | 73492-716 | Ointment | Over the counter monograph drugs | July 18, 2023 |
| Hemorrhoid Relief Cream | 73492-712 | Cream | Over the counter monograph drugs | January 28, 2022 |
| Ultra Strength Pain Relief Balm | 73492-711 | Ointment | Over the counter monograph drugs | January 27, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.